Jan Nilsson

Jan Nilsson currently works at Annexin Pharmaceuticals AB, as Chairman from 2024, CCRM Nordic AB, as Chairman, CanImGuide Therapeutics AB, as Non-Executive Director, Panion Animal Health AB, as Director from 2019, Urbicum Ledningskonsult AB, as Director, CarryGenes Therapeutics AB, as Director, and Immodulate Pharma AB, as Director.
Mr. Nilsson also formerly worked at Promore Pharma AB, as Chief Executive Officer & Director from 2011 to 2013, CombiGene AB, as Chief Executive Officer & Director, Abliva AB, as Chief Operating Officer in 2016, and Pergamum AB, as Chief Commercial Officer.
Mr. Nilsson received his Masters Business Admin degree from the University of Uppsala and graduate degree from the University of Gothenburg.